RNS Number : 5004B
Maven Income & Growth VCT PLC
02 June 2023
 


Maven Income and Growth VCT PLC (the Company)

 

Issue of Equity

 

On 7 October 2022, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £10 million (the Offer).

 

Pursuant to the Offer, £884,869 of valid applications were received in the period from 7 October 2022 up to 12 noon on 26 May 2023 in respect of the 2023/2024 tax year. This is the first and final allotment in respect of the 2023/2024 tax year and, as a result, the Company has issued and allotted 2,013,349 new Ordinary Shares on 2 June 2023. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 43.44p to 44.15p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 148,939,237. Therefore, the total number of voting rights in the Company is 148,939,237.

 

The total funds raised by the Company for the 2022/2023 and the 2023/2024 tax years is £6,740,117.

 

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective, and dealings will commence on or around 6 June 2023.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

2 June 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEVLLBBXQLXBBD